IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
468.20
-2.54 (-0.54%)
At close: Jul 19, 2024, 4:00 PM
461.10
-7.10 (-1.52%)
Pre-market: Jul 22, 2024, 4:21 AM EDT

IDEXX Laboratories Revenue

IDEXX Laboratories had revenue of $3.72B in the twelve months ending March 31, 2024, with 8.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $964.10M with 7.10% year-over-year growth. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.

Revenue (ttm)
$3.72B
Revenue Growth
+8.57%
P/S Ratio
10.38
Revenue / Employee
$338,623
Employees
11,000
Market Cap
38.67B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.66B293.63M8.72%
Dec 31, 20223.37B151.96M4.73%
Dec 31, 20213.22B508.71M18.79%
Dec 31, 20202.71B299.75M12.45%
Dec 31, 20192.41B193.67M8.75%
Dec 31, 20182.21B244.18M12.40%
Dec 31, 20171.97B193.64M10.91%
Dec 31, 20161.78B173.53M10.83%
Dec 31, 20151.60B116.09M7.81%
Dec 31, 20141.49B108.75M7.90%
Dec 31, 20131.38B83.72M6.47%
Dec 31, 20121.29B74.65M6.13%
Dec 31, 20111.22B115.30M10.45%
Dec 31, 20101.10B71.76M6.96%
Dec 31, 20091.03B7.60M0.74%
Dec 31, 20081.02B101.48M11.00%
Dec 31, 2007922.56M183.44M24.82%
Dec 31, 2006739.12M101.02M15.83%
Dec 31, 2005638.10M88.91M16.19%
Dec 31, 2004549.18M73.19M15.38%
Dec 31, 2003475.99M63.32M15.34%
Dec 31, 2002412.67M26.59M6.89%
Dec 31, 2001386.08M18.65M5.08%
Dec 31, 2000367.43M9.06M2.53%
Dec 31, 1999358.37M36.66M11.39%
Dec 31, 1998321.71M58.74M22.34%
Dec 31, 1997262.97M-4.71M-1.76%
Dec 31, 1996267.68M79.08M41.93%
Dec 31, 1995188.60M62.24M49.25%
Dec 31, 1994126.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Centene 155.52B
Takeda Pharmaceutical 28.16B
GE HealthCare Technologies 19.50B
IQVIA Holdings 15.07B
Haleon 14.31B
Biogen 9.66B
Alcon 9.56B
Agilent Technologies 6.59B
Revenue Rankings